Reviewer Board
Members of the reviewer board are selected from all Current Oncology reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.
Members
Department of Gastroenterology, Kyoto Okamoto Memorial Hospital, 100 Nishinokuchi, Sayama, Kumiyama-cho, Kuze-gun, Kyoto 613-0034, Japan
Interests: gastric; hepato-biliary-pancreatic cancer; gastrointestinal cancer; ERCP; EUS; interventional endoscopy; palliative medicine; cancer screening
Interests: gastric; hepato-biliary-pancreatic cancer; gastrointestinal cancer; ERCP; EUS; interventional endoscopy; palliative medicine; cancer screening
Division of Biochemistry, School of Medicine, Loma Linda University, Loma Linda, CA, USA
Interests: genetics in cancer; epigenetic regulation (methylation, microRNA); endocrine cancer; cancer progression; cancer therapeutics
Interests: genetics in cancer; epigenetic regulation (methylation, microRNA); endocrine cancer; cancer progression; cancer therapeutics
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cukurova University Faculty of Medicine, Adana, Turkey
Interests: cancer; surgery
Interests: cancer; surgery
CHU UCL Namur
Interests: body fluids; platelets; clinical chemistry; serology; hematology
Interests: body fluids; platelets; clinical chemistry; serology; hematology
Department of Medicine at NYU Grossman School of Medicine, New York, NY, USA
Interests: lung cancer; targeted therapies; Immunology; immunotherapy; biomarker
Interests: lung cancer; targeted therapies; Immunology; immunotherapy; biomarker
1. Fels Cancer Institute for Personalized Medicine, Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA
2. Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 02-093 Warsaw, Poland
Interests: leukemia; DNA repair; DNA damage response; PARP inhibitor; POLQ inhibitor; bone marrow microenvironment; cell signaling; DNA methylation
2. Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 02-093 Warsaw, Poland
Interests: leukemia; DNA repair; DNA damage response; PARP inhibitor; POLQ inhibitor; bone marrow microenvironment; cell signaling; DNA methylation
Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA
Interests: DNA damage and response; cancer target therapy
Interests: DNA damage and response; cancer target therapy
First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Interests: population genetics; cancer therapy; cancer evolution; single cell sequencing; computational biology
Interests: population genetics; cancer therapy; cancer evolution; single cell sequencing; computational biology
Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Interests: population genetics; cancer genomics; machine learning; computational mathematics
Interests: population genetics; cancer genomics; machine learning; computational mathematics
1. Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto) & Porto Comprehensive Cancer Center (P.CCC), 4200-072 Porto, Portugal
2. Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), 4200-072 Porto, Portugal
3. Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), 4200-072 Porto, Portugal
Interests: biomarkers; bladder cancer; epigenetics; histones; kidney cancer; methylation; microRNAs; pathology; prostate cancer; testicular germ cell tumors; uropathology
2. Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), 4200-072 Porto, Portugal
3. Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto (ICBAS-UP), 4200-072 Porto, Portugal
Interests: biomarkers; bladder cancer; epigenetics; histones; kidney cancer; methylation; microRNAs; pathology; prostate cancer; testicular germ cell tumors; uropathology
Medical Oncologist, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada
Interests: breast cancer; systemic therapies; real-world outcomes; risk assessment; prevention
Interests: breast cancer; systemic therapies; real-world outcomes; risk assessment; prevention
School of Medical and Life Sciences, Sunway University, Sunway City 47500, Malaysia
Interests: clinical medicine; cancer research; biomedical sciences
Interests: clinical medicine; cancer research; biomedical sciences
Department of Radiology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City 700000, Vietnam
Interests: diagnostic radiology; interventional radiology; brain tumors; pediatric radiology; neurooncology; neuroradiology; oncology
Interests: diagnostic radiology; interventional radiology; brain tumors; pediatric radiology; neurooncology; neuroradiology; oncology
Institute of Cytology of the Russian Academy of Sciences, St. Petersburg, Russia
Interests: breast cancer; biomarker; proteomics; mass spectrometry; proteasome biology
Interests: breast cancer; biomarker; proteomics; mass spectrometry; proteasome biology
Beckman Research Institute of City of Hope, Monrovia, CA, USA
Interests: myeloma; cancer immunology
Interests: myeloma; cancer immunology
Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Interests: soft-tissue sarcomas; immunotherapy; neoadjuvant treatment; the mTOR pathway; leiomyosarcomas; undifferentiated pleomorphic sarcomas
Interests: soft-tissue sarcomas; immunotherapy; neoadjuvant treatment; the mTOR pathway; leiomyosarcomas; undifferentiated pleomorphic sarcomas
1. Cancer Trials Ireland, Dublin, Ireland
2. Cork University Hospital, Cork, Ireland
Interests: clinical trials; breast cancer; climate change; cybersecurity; survivorship
2. Cork University Hospital, Cork, Ireland
Interests: clinical trials; breast cancer; climate change; cybersecurity; survivorship
Department of Neurosurgery, University of Cincinnati College of Medicine, Cincinnati, OH 45220, USA
Interests: artificial intelligence; neuro-oncology; neurosurgery; skull base; spine; surgery
Interests: artificial intelligence; neuro-oncology; neurosurgery; skull base; spine; surgery
Department of Neurosciences, Reproductive & Odontostomatological Sciences, Urology & Andrology Unit, Federico II University of Naples, 80131 Naples, Italy.
Interests: renal; prostate; radiofrequency ablation; cancer; kidney cancer; prostate cancer; bladder cancer; urology; andrology; microwave ablation
Interests: renal; prostate; radiofrequency ablation; cancer; kidney cancer; prostate cancer; bladder cancer; urology; andrology; microwave ablation
Hormel Institute, a Medical Research Center
University of Minnesota,
Austin, MN, USA 55912
Interests: polycystic liver diseases; molecular biology of cancer cells; NASH; cholangiocarcinoma; hepatocellular carcinoma
Interests: polycystic liver diseases; molecular biology of cancer cells; NASH; cholangiocarcinoma; hepatocellular carcinoma
Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA 99202, USA
Interests: cancer biology; tumor microenvironment; precision oncology; molecular targeted therapies; biomarkers; cancer genomics; drug resistance mechanisms; cancer metastasis; therapeutic strategies
Interests: cancer biology; tumor microenvironment; precision oncology; molecular targeted therapies; biomarkers; cancer genomics; drug resistance mechanisms; cancer metastasis; therapeutic strategies
Division of Medical Oncology, Nova Scotia Cancer Centre and Dalhousie University, Halifax, NS B3H 2Y9, Canada
Interests: pancreatic cancer; hepatocellular carcinoma; cholangiocarcinoma; translational research; real world evidence
Interests: pancreatic cancer; hepatocellular carcinoma; cholangiocarcinoma; translational research; real world evidence
Department of Molecular and Integrative Physiology, University of Michigan, 7703 Medical Science Building II, 1301 East Catherine Street, Ann Arbor, MI 48109-5622, USA
Interests: hypoxia; hypoxia inducible factors; cancer metabolism; tumor immunology; immunometabolism; cancer immunotherapy; tumor microenvironment; colon cancer; oxidative cell death; ferroptosis
Interests: hypoxia; hypoxia inducible factors; cancer metabolism; tumor immunology; immunometabolism; cancer immunotherapy; tumor microenvironment; colon cancer; oxidative cell death; ferroptosis
Department of Anatomy, University of California, San Francisco, CA 94143, USA
Interests: cancer biology; pancreatic cancer; therapy resistance; iron metabolism; autophagy and lysosomes; epigenetics; DNA methylation/demethylation and histone modifications; cell biology; developmental biology; embryonic stem cell biology
Interests: cancer biology; pancreatic cancer; therapy resistance; iron metabolism; autophagy and lysosomes; epigenetics; DNA methylation/demethylation and histone modifications; cell biology; developmental biology; embryonic stem cell biology
1. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA
2. Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN 55905, USA
Interests: neuro-oncology; neurosurgery; glioma; glioblastoma; DIPG; diffuse midline glioma; H3K27M; targeted therapy; drug delivery; convection-enhanced delivery
2. Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN 55905, USA
Interests: neuro-oncology; neurosurgery; glioma; glioblastoma; DIPG; diffuse midline glioma; H3K27M; targeted therapy; drug delivery; convection-enhanced delivery
1. Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy
2. Oncologia Medica, Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni, Bologna, Italy
Interests: biliary tract cancer; cholangiocarcinoma; renal carcinoma; gastric cancer; renal cell carcinoma; bladder cancer; hepatocellular carcinoma; radiofrequency ablation; immunotherapy; urothelial carcinoma; targeted therapies; uterine sarcoma; gallbladder cance
2. Oncologia Medica, Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni, Bologna, Italy
Interests: biliary tract cancer; cholangiocarcinoma; renal carcinoma; gastric cancer; renal cell carcinoma; bladder cancer; hepatocellular carcinoma; radiofrequency ablation; immunotherapy; urothelial carcinoma; targeted therapies; uterine sarcoma; gallbladder cance
Dipartimento di Scienze della Sanità Pubblica e Pediatriche, Univeristà di Torino, Torino, Italy
Interests: professionals; pediatric; oncology
Interests: professionals; pediatric; oncology
Harvard Medical School, Boston Children's Hospital, Boston, MA 02115, USA
Interests: cancer immunology; cancer prevention; cell signaling; phytochemicals; renal cancer
Interests: cancer immunology; cancer prevention; cell signaling; phytochemicals; renal cancer
Department of Medical Oncology, Dana-Farber Cancer Institute-Harvard Medical School, 450 Brookline Ave, Boston, MA 02215, USA
Interests: breast cancer; gastric cancer; esophageal cancer; colorectal cancer; DNA-damage response; membrane receptors; cell invasion; signaling; cell and molecular biology; molecular medicine; drug discovery; genomics; genome sequencing; genetics; epigenetics
Interests: breast cancer; gastric cancer; esophageal cancer; colorectal cancer; DNA-damage response; membrane receptors; cell invasion; signaling; cell and molecular biology; molecular medicine; drug discovery; genomics; genome sequencing; genetics; epigenetics
Division of Experimental Pathology and Laboratory Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Interests: quinacrine; ribosomal biogenesis; nucleolar stress; nucleostemin; chemotherapy resistance; ovarian cancer
Interests: quinacrine; ribosomal biogenesis; nucleolar stress; nucleostemin; chemotherapy resistance; ovarian cancer
